Dr. Reddy's Laboratories Limited
RDY
$12.66
-$0.045-0.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 641.44M | 639.78M | 668.92M | 672.77M | 632.07M |
| Total Depreciation and Amortization | 193.71M | 183.13M | 181.51M | 179.27M | 173.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.05M | 11.93M | -34.47M | -59.04M | -24.91M |
| Change in Net Operating Assets | -397.94M | -426.14M | -301.65M | -243.62M | -130.44M |
| Cash from Operations | 430.17M | 408.70M | 514.30M | 549.39M | 650.08M |
| Capital Expenditure | -299.57M | -260.46M | -215.05M | -198.09M | -166.35M |
| Sale of Property, Plant, and Equipment | 6.87M | 11.85M | 14.99M | 12.83M | 12.50M |
| Cash Acquisitions | -614.12M | -614.12M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 235.12M | 61.27M | -428.36M | -300.68M | -387.31M |
| Cash from Investing | -671.70M | -801.46M | -628.42M | -485.94M | -541.16M |
| Total Debt Issued | 29.76B | 33.05B | 16.06B | 9.29B | 8.92B |
| Total Debt Repaid | -1.31B | -304.00M | -456.00M | -4.95B | -8.81B |
| Issuance of Common Stock | 213.00M | 197.00M | 745.00M | 805.00M | 995.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -79.53M | -79.53M | -80.41M | -80.41M | -80.41M |
| Other Financing Activities | 3.75B | 4.16B | -2.45B | -2.27B | -1.98B |
| Cash from Financing | 307.75M | 364.22M | 86.31M | -46.03M | -91.90M |
| Foreign Exchange rate Adjustments | -912.80K | 1.08M | 556.90K | -730.20K | -1.02M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.30M | -27.46M | -27.25M | 16.69M | 16.00M |
